These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17336622)

  • 1. "Black box" warnings and drug surveillance.
    Menendez R
    J Allergy Clin Immunol; 2007 Mar; 119(3):759; author reply 759-60. PubMed ID: 17336622
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure to recognize adverse drug reactions despite warnings.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1999 Mar; 18(1):1-3. PubMed ID: 10401518
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse drug reactions: moving from chance to science.
    Haller C; James LP
    Clin Pharmacol Ther; 2011 Jun; 89(6):761-4. PubMed ID: 21593747
    [No Abstract]   [Full Text] [Related]  

  • 4. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
    Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
    Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD.
    Schuemie MJ
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):292-9. PubMed ID: 20945505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How should we react to adverse drug reactions?
    Ferner RE; Beard K
    Postgrad Med J; 2011 Feb; 87(1024):81-2. PubMed ID: 21303818
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse drug effects: involvement of physicians demanded].
    Hügler S
    Dtsch Med Wochenschr; 2009 Apr; 134(17):p16. PubMed ID: 19399721
    [No Abstract]   [Full Text] [Related]  

  • 8. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active surveillance of serious adverse drug reactions in New Zealand children.
    Kunac D; Tatley MV; Grimwood K; Reith DM
    Arch Dis Child; 2012 Aug; 97(8):761-2. PubMed ID: 22563042
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse drug reactions in childhood: a review of prospective studies and safety alerts.
    Clavenna A; Bonati M
    Arch Dis Child; 2009 Sep; 94(9):724-8. PubMed ID: 19531524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision support methods for the detection of adverse events in post-marketing data.
    Hauben M; Bate A
    Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European drug agency criticises Roche for failing to report adverse reactions and patient deaths.
    Wise J
    BMJ; 2012 Jun; 344():e4344. PubMed ID: 22736470
    [No Abstract]   [Full Text] [Related]  

  • 13. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse.
    Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674
    [No Abstract]   [Full Text] [Related]  

  • 14. [Safe drugs for children].
    Krankenpfl J; 2004; 42(7-10):230. PubMed ID: 15675392
    [No Abstract]   [Full Text] [Related]  

  • 15. Modeling, building and evaluating an ontology for the automatic characterization of adverse drug effects during pharmacovigilance.
    Duclos C; Soualmia LF; Krivine S; Jamet A; Lillo-Louët A
    Stud Health Technol Inform; 2010; 160(Pt 2):1005-9. PubMed ID: 20841835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidality following black-box warning.
    Wolf DV
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):405. PubMed ID: 15843759
    [No Abstract]   [Full Text] [Related]  

  • 17. Surveying adverse event rates: lessons from a virosomal hepatitis A vaccine.
    Herzog C
    Expert Rev Vaccines; 2012 Apr; 11(4):383-5. PubMed ID: 22551020
    [No Abstract]   [Full Text] [Related]  

  • 18. Short patent lives jeopardize drug and patient safety.
    Hondeghem LM; De Clerck F; Camm J
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):353-7. PubMed ID: 18049301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced fatal adverse effects in the United States from 1999 to 2004].
    He M; Guo QL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1060-5. PubMed ID: 19060378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.